Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-21

Clinical Trial Update: The Role of Montelukast in Rhinitis and Sleep [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluated montelukast for perennial allergic rhinitis and sleep outcomes; results were posted in 2014. The study was sponsored by Penn St…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Montelukast (Montelukast)

Snippet

Sponsor: Penn State University | Conditions: Perennial Allergic Rhinitis | Phase 4 | Status: COMPLETED | Results posted: 2014-10-21